Serum free light chain evaluation as a marker for the impact of intra-clonal heterogeneity on the progression and treatment resistance in multiple myeloma.
January 1st 2014 • Brioli A, Giles H, Pawlyn C, Campbell J, Kaiser M, Melchor L et al. • Blood 2014;123:3414-9 PMID:24733348